Evidence map›Paper›PMID 31067407›Full record

ArticleACS nano2019

Supramolecular Polymer Hydrogels for Drug-Induced Tissue Regeneration.

Jing Cheng, Devang Amin, Jessica Latona, Ellen Heber-Katz, Phillip B Messersmith

Open access · greenAbstract read
In one paragraph

Article in ACS nano, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. The influence of molecular design on structure-property relationships of a supramolecular polymer prodrug.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Oxygen-sensing mechanisms in development and tissue repair.Development (Cambridge, England) · 2021
    Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Jing ChengDepartments of Bioengineering and Materials Science and Engineering , University of California, Berkeley , 210 Hearst Mining Building , Berkeley , California 94720 , United States.ORCID 0000-0002-5379-2203
Devang AminDepartment of Biomedical Engineering , Northwestern University , Evanston , Illinois 60208 , United States.
Jessica LatonaLaboratory of Regenerative Medicine , Lankenau Institute for Medical Research , Wynnewood , Pennsylvania 19096 , United States.
Ellen Heber-KatzLaboratory of Regenerative Medicine , Lankenau Institute for Medical Research , Wynnewood , Pennsylvania 19096 , United States.
Phillip B MessersmithDepartments of Bioengineering and Materials Science and Engineering , University of California, Berkeley , 210 Hearst Mining Building , Berkeley , California 94720 , United States.ORCID 0000-0002-1197-333X
Lankenau Institute for Medical Research · USHearst (United States) · USLawrence Berkeley National Laboratory · USNorthwestern University · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM008152 · NIGMS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI ARDEHALI, HOSSEIN · 1987 to 2021
$24.0M
Regenerative wound healing via inflammation-modulating biomaterialsR01DE021104 · NIDCR · WISTAR INSTITUTE · PI Georgios Hajishengallis, Ellen s. Heber-Katz · 2011 to 2026
$8.5M
Developing Capacity to Evaluate Training Programs via Development of Human, Institutional and Social CapitalT32GM008449 · NIGMS · NORTHWESTERN UNIVERSITY · PI LEONARD, JOSHUA NATHANIEL · 1993 to 2023
$7.8M
Does Inflammation Enhance Rengeneration?R01DE021215 · NIDCR · WISTAR INSTITUTE · PI HEBER-KATZ, ELLEN S., MESSERSMITH, PHILLIP B · 2010 to 2013
$1.3M
NIDCR NIH HHS R01 DE021104NIDCR NIH HHS R01 DE021215NIGMS NIH HHS T32 GM008152NIGMS NIH HHS T32 GM008449
6 · The paper itself

Abstract

Supramolecular polymers self-assemble into nanofibers, micelles, and other nanostructures through weak noncovalent interactions between subunits. Such systems possess attractive properties for use in a variety of practical settings such as energy, sustainability, and healthcare. In regenerative medicine, a common approach involves implanting a supramolecular material containing cell and growth factor binding motifs directly into a diseased or traumatized tissue defect, whereupon it interacts with and/or recruits components of the biological system to induce tissue healing. Here we introduce a supramolecular therapeutic in which tissue regeneration is orchestrated by a supramolecular polymer prodrug implanted subcutaneously in a remote tissue. Our approach exploits a hydrophobic small-molecule inhibitor of prolyl hydroxylase enzyme as both a regeneration-inducing therapeutic and a structure-directing agent in a supramolecular polymer that forms shear-thinning nanofiber hydrogels. Subcutaneous injection of the supramolecular hydrogel in the back of mice wounded with a critical-sized defect in the ear led to transient upregulation of hypoxia inducible factor-1α and regeneration of ear tissue in a manner reminiscent of epimorphic regeneration. This drug-induced regeneration strategy utilizes a simple and translatable supramolecular design, eliminates the need for delivery of biologics ( e. g., growth factors, cells), and avoids implantation of a foreign material directly in a tissue defect.

Indexed as

Drug Delivery SystemsAnimalsEarHumansHydrogelsHydrophobic and Hydrophilic InteractionsHypoxia-Inducible Factor 1, alpha SubunitMicePolymersProlyl-Hydroxylase InhibitorsProlyl HydroxylasesRegenerationSmall Molecule LibrariesHif1a protein, mouseHydrogelsHypoxia-Inducible Factor 1, alpha SubunitPolymersProlyl-Hydroxylase InhibitorsProlyl HydroxylasesSmall Molecule Librariesdrug deliveryhypoxia-inducible factorself-assemblysupramolecular polymertissue regeneration

Identifiers

PMID31067407
PMCPMC8232973
OpenAlexW2944145450

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.